‘Tremendous Potential’: David McMullen Discusses FDA Perspective On Mental Health Apps
US FDA neurological device office head David McMullen is watching digital health tools make mental health treatments more widely available than ever before, though the expansion comes with some risks. Medtech Insight spoke with him about the FDA’s role in this growing field.
